Drawing for ISOLAGEN

USPTO serial 76058887

ISOLAGEN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
DALIER, JOHN DAVID
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ISOLAGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Richard P. Ferrara

RICHARD P FERRARA FISH & RICHARDSON PC45 ROCKEFELLER PLZ STE 2800NEW YORK, NY 10111-0100UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042Medical and laboratory services, namely, growing and providing a supply of histocompatible fibroblast cells for use in cosmetic proceduresACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 27, 2004MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 27, 2004ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 1, 2004CFITCASE FILE IN TICRS—
Feb 19, 2004EX5GSOU EXTENSION 5 GRANTED—
Feb 19, 2004EXT5SOU EXTENSION 5 FILED—
Feb 19, 2004EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 4, 2003EX4GSOU EXTENSION 4 GRANTED—
Aug 11, 2003EXT4SOU EXTENSION 4 FILED—
Aug 11, 2003MAILPAPER RECEIVED—
May 12, 2003EX3GSOU EXTENSION 3 GRANTED—
Feb 24, 2003EXT3SOU EXTENSION 3 FILED—
Feb 24, 2003MAILPAPER RECEIVED—
Sep 12, 2002EX2GSOU EXTENSION 2 GRANTED—
Aug 15, 2002MAILPAPER RECEIVED—
Aug 12, 2002EXT2SOU EXTENSION 2 FILED—
Mar 22, 2002EX1GSOU EXTENSION 1 GRANTED—
Feb 22, 2002EXT1SOU EXTENSION 1 FILED—
Aug 28, 2001NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 5, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 23, 2001NPUBNOTICE OF PUBLICATION—
Jan 19, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 10, 2001CNEAEXAMINER'S AMENDMENT MAILED—
Nov 6, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 23, 2000DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance